Complications of Intravitreal Ocriplasmin in the Treatment of Symptomatic Vitreomacular Adhesion

被引：0
|
作者：
Feng, Henry L. [1 ]
Roth, Daniel B. [1 ]
Modi, Kunjal K. [1 ]
Fine, Howard F. [1 ]
Wheatley, Harold M. [1 ]
机构：
[1] Robert Wood Johnson Med Sch, Piscataway, NJ USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
763; vitreous; 688; retina; 561; injection;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
308
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Intravitreal Ocriplasmin for Symptomatic Vitreomacular Adhesion
    Warrow, David
    Patel, Auvni
    Raevis, Joseph
    Lai, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [2] Predictors of Success with Intravitreal Ocriplasmin in the Treatment of Symptomatic Vitreomacular Adhesion
    Roth, Daniel B.
    Feng, Henry L.
    Modi, Kunjal K.
    Fine, Howard F.
    Wheatley, Harold M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [3] Initial Outcomes Following Intravitreal Ocriplasmin for Treatment of Symptomatic Vitreomacular Adhesion
    Kim, Brian T.
    Schwartz, Stephen G.
    Smiddy, William E.
    Doshi, Rishi R.
    Kovach, Jaclyn L.
    Berrocal, Audina M.
    Moshfeghi, Andrew A.
    Fortun, Jorge A.
    OPHTHALMIC SURGERY LASERS & IMAGING, 2013, 44 (04) : 334 - 343
  • [4] Efficacy of Intravitreal Ocriplasmin for Treatment of Vitreomacular Adhesion
    Haller, Julia A.
    Stalmans, Peter
    Benz, Matthew S.
    Gandorfer, Arnd
    Pakola, Stephen J.
    Girach, Aniz
    Kampik, Anselm
    Jaffe, Glenn J.
    Toth, Cynthia A.
    OPHTHALMOLOGY, 2015, 122 (01) : 117 - 122
  • [5] Ocriplasmin for symptomatic vitreomacular adhesion
    Neffendorf, James E.
    Kirthi, Varo
    Pringle, Edward
    Jackson, Timothy L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (10):
  • [6] SAFETY PROFILE OF OCRIPLASMIN FOR THE PHARMACOLOGIC TREATMENT OF SYMPTOMATIC VITREOMACULAR ADHESION/TRACTION
    Kaiser, Peter K.
    Kampik, Anselm
    Kuppermann, Baruch D.
    Girach, Aniz
    Rizzo, Stanislao
    Sergott, Robert C.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (06): : 1111 - 1127
  • [7] Budget impact analysis of ocriplasmin for the treatment of symptomatic vitreomacular adhesion in the USA
    Yu, Tiffany M.
    Dugel, Pravin U.
    Haller, Julia A.
    Kaiser, Peter K.
    Arnold, Renee J. G.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (12) : 1195 - 1207
  • [8] COST EFFECTIVENESS OF OCRIPLASMIN FOR TREATMENT OF SYMPTOMATIC VITREOMACULAR ADHESION IN THE UNITED STATES
    Schmidt, R.
    Bennison, C.
    Khanani, A. M.
    Wagner, A.
    Dugel, P. U.
    Haller, J.
    Lescrauwaet, B.
    VALUE IN HEALTH, 2018, 21 : S427 - S427
  • [9] Intravitreal ocriplasmin: A breakthrough in the treatment of vitreomacular traction?
    Mec-Slomska, Anna E.
    Adamiec-Mroczek, Joanna
    Kuzmicz, Ewa
    Misiuk-Hojlo, Marta
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (03): : 527 - 531
  • [10] Ocriplasmin: A guide to its use in symptomatic vitreomacular adhesion
    Keating G.M.
    Syed Y.Y.
    Dhillon S.
    Drugs & Therapy Perspectives, 2014, 30 (5) : 161 - 165
12345